Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00TQN
|
|||
| Former ID |
DIB004372
|
|||
| Drug Name |
JTK-003
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Discontinued in Phase 2 | [1] | |
| Company |
Japan Tobacco Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mycobacterium RNA polymerase (MycB RNAP) | Target Info | Inhibitor | [2] |
| KEGG Pathway | Purine metabolism | |||
| Pyrimidine metabolism | ||||
| Metabolic pathways | ||||
| RNA polymerase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017555) | |||
| REF 2 | Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care. Viruses. 2010 April; 2(4): 826-866. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.